| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairman, President & CEO | President & CEO | President & COO +3 more
1 company
Noel R. Wallace is Chairman, President & CEO at CL. Noel R. Wallace's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $36.3M at current prices.
Our model assigns Noel R. Wallace a middling insider score of 59/100, based on 17 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -2.8%.
The CL filings lean toward selling, a net 1,535,468 shares.
Noel R. Wallace has 54 Form 4 filings on record from February 2017 to September 2026, across 2 companies: Director at American Express (AXP), 2026; Chairman, President & CEO at Colgate-Palmolive (CL), 2017–2026.
The 96 reported transactions were 32 open-market sales, 20 option exercises, 16 tax withholdings and 14 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 26 sales worth about $124.4M.
The largest open-market sale was 322,042 shares of CL at an average $92.22 on August 5, 2026, about $29.7M.
5 of the 7 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other 2 were not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | CL Colgate-Palmolive Company | Chairman, President & CEO | Sale+OE | 322,042 | $92.22 | $29,698,616.63 | -47.1% | -0.1% | - | |
| Feb 4, 2026 | CL Colgate-Palmolive Company | Chairman, President & CEO | Sell | 45,568 | $93.91 | $4,279,495.94 | -13.5% | -8.5% | - | |
| Nov 22, 2024 | CL Colgate Palmolive Co | Chairman, President & CEO | Sell10b5-1 | 33,333 | $95.00 | $3,166,635.00 | -11.0% | -7.4% | -14.7% | |
| Feb 20, 2024 | CL Colgate Palmolive Co | Chairman, President & CEO | Sale+OE10b5-1 | 99,720 | $84.17 | $8,393,551.20 | -25.8% | +11.6% | +3.3% | |
| Feb 12, 2024 | CL Colgate Palmolive Co | Chairman, President & CEO | Sale+OE10b5-1 | 50,000 | $83.15 | $4,157,280.00 | -15.4% | +13.0% | +4.6% | |
| Sep 11, 2023 | CL Colgate Palmolive Co | Chairman, President & CEO | Sale+OE10b5-1 | 48,627 | $73.37 | $3,567,981.81 | -16.5% | +5.0% | +44.5% | |
| May 8, 2023 | CL Colgate Palmolive Co | Chairman, President & CEO | Sale+OE10b5-1 | 50,000 | $80.66 | $4,032,920.00 | -16.9% | -4.8% | +16.5% | |
| Aug 4, 2022 | CL Colgate Palmolive Co | Chairman, President & CEO | Sale+OE | 51,665 | $81.27 | $4,198,897.21 | -18.9% | -9.4% | -5.1% | |
| Jun 6, 2022 | CL Colgate Palmolive Co | Chairman, President & CEO | Sale+OE | 50,000 | $79.34 | $3,966,905.00 | -18.4% | -0.7% | -2.9% | |
| Feb 18, 2022 | CL Colgate Palmolive Co | Chairman, President & CEO | Sell | 38,583 | $79.33 | $3,060,824.11 | -14.8% | -5.0% | -4.6% |